|
시장보고서
상품코드
1967852
3D 프린트 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global 3D Printed Drugs Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
3D 프린트 의약품 시장 규모는 2025년 1억 4,685만 달러에서 2034년에는 5억 3,467만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 15.44%로 성장할 전망입니다.
세계 3D 프린팅 의약품 시장은 제약 분야에서의 적층제조 기술의 발전에 힘입어 새로운 성장을 거듭하고 있습니다. 정밀한 용량 제어와 복잡한 방출 메커니즘을 갖춘 맞춤형 의약품 제조 능력은 맞춤형 의료에 새로운 기회를 가져다주었습니다. 상업화 초기 단계이지만, 연구 투자 증가와 파일럿 규모의 생산시설 구축으로 꾸준한 시장 확대에 기여하고 있습니다.
주요 촉진요인으로는 환자 맞춤형 치료법에 대한 수요 증가, 희귀질환 치료제에 대한 관심 증가, 개선된 약물전달 시스템의 필요성 등을 들 수 있습니다. 3D 프린팅 기술을 통해 다층 정제나 여러 약물을 단일 용량으로 통합한 폴리필(복합제) 제조가 가능해져 환자의 복약 순응도 강화에 기여할 수 있습니다. 인쇄 가능한 제약 등급 재료의 기술적 진보와 규제 측면의 발전도 업계의 발전을 지원하고 있습니다.
향후 규제 당국의 광범위한 승인과 확장 가능한 제조 솔루션의 확립으로 병원 및 전문 약국에서의 보급이 가속화될 것으로 예측됩니다. 의료시설내 온디맨드 의약품 제조는 공급망 복잡성 및 의약품 부족을 완화하는 데 기여할 수 있습니다. 제약회사들이 혁신에 대한 투자를 지속하는 가운데, 3D 프린팅 의약품은 특히 소아과와 정밀의료 분야에서 틈새 시장에서 주류 치료 분야로 전환될 것으로 예측됩니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 3D 프린트 의약품 시장 : 제공별
제5장 세계의 3D 프린트 의약품 시장 : 방법별
제6장 세계의 3D 프린트 의약품 시장 : 적응증별
제7장 세계의 3D 프린트 의약품 시장 : 최종사용자별
제8장 세계의 3D 프린트 의약품 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.03.24The 3D Printed Drugs Market size is expected to reach USD 534.67 Million in 2034 from USD 146.85 Million (2025) growing at a CAGR of 15.44% during 2026-2034.
The global 3D printed drugs market is witnessing emerging growth driven by advancements in additive manufacturing technologies within the pharmaceutical sector. The ability to manufacture customized medications with precise dosage control and complex release mechanisms has created new opportunities in personalized medicine. Although still in early commercialization stages, increasing research investments and pilot-scale production facilities are contributing to steady market expansion.
Major drivers include the rising demand for patient-specific therapies, growing focus on orphan drugs, and the need for improved drug delivery systems. 3D printing allows the production of multi-layer tablets and polypills that combine multiple medications into a single dose, enhancing patient compliance. Technological advancements in printable pharmaceutical-grade materials and regulatory progress are also supporting industry development.
In the future, broader regulatory acceptance and scalable manufacturing solutions will accelerate adoption across hospitals and specialty pharmacies. On-demand drug production at healthcare facilities may reduce supply chain complexities and drug shortages. As pharmaceutical companies continue investing in innovation, 3D printed drugs are expected to transition from niche applications to mainstream therapeutic segments, particularly in pediatrics and precision medicine.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Offering
- Spritam (Levetiracetam)
- T22
- T20G
By Technique
- 3D Inkjet Printing
- Selective Laser Sintering (SLS) 3D Printing
- Melt Extrusion Deposition (MED)
By Indication
- Neurological Disorders
- Cardiovascular Diseases
- Others
By End User
- Pharmacies
- Hospitals
- Others
COMPANIES PROFILED
- Aprecia Pharmaceuticals, Triastek Inc, FabRx Ltd, GlaxoSmithKline plc, AstraZeneca plc, Merck KGaA, Cycle Pharmaceuticals, Osmotica Pharmaceuticals, Affinity Therapeutics, Extend Biosciences
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL 3D PRINTED DRUGS MARKET: BY OFFERING 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Offering
- 4.2. Spritam (Levetiracetam) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. T22 Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. T20G Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL 3D PRINTED DRUGS MARKET: BY TECHNIQUE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Technique
- 5.2. 3D Inkjet Printing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Selective Laser Sintering (SLS) 3D Printing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Melt Extrusion Deposition (MED) Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL 3D PRINTED DRUGS MARKET: BY INDICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Indication
- 6.2. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL 3D PRINTED DRUGS MARKET: BY END USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End User
- 7.2. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL 3D PRINTED DRUGS MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Offering
- 8.2.2 By Technique
- 8.2.3 By Indication
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Offering
- 8.3.2 By Technique
- 8.3.3 By Indication
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Offering
- 8.4.2 By Technique
- 8.4.3 By Indication
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Offering
- 8.5.2 By Technique
- 8.5.3 By Indication
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Offering
- 8.6.2 By Technique
- 8.6.3 By Indication
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL 3D PRINTED DRUGS INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Aprecia Pharmaceuticals
- 10.2.2 Triastek Inc
- 10.2.3 FabRx Ltd
- 10.2.4 GlaxoSmithKline Plc
- 10.2.5 AstraZeneca Plc
- 10.2.6 Merck KGaA
- 10.2.7 Cycle Pharmaceuticals
- 10.2.8 Osmotica Pharmaceuticals
- 10.2.9 Affinity Therapeutics
- 10.2.10 Extend Biosciences
